CAS: 123441-03-2 - Rivastigmine
Formula:C14H22N2O2
InChI:InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1
InChI key:InChIKey=XSVMFMHYUFZWBK-NSHDSACASA-N
SMILES:O=C(OC1=CC=CC(=C1)C(N(C)C)C)N(C)CC
- Synonyms:
- 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate
- 3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
- 3-[1-(Dimethylamino)Ethyl]Phenyl Ethyl(Methyl)Carbamate
- Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
- Carbamic acid, ethylmethyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
- Carbamic acid, ethylmethyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, (S)-
- ENA 713 free base
- Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
- Exelon
- Nimvastid
- See more synonyms
- Prometax
- Rivastach
- Rivastigimine(Forr&Donly)
- Rivastigmine Base
- S-Rivastigmine
- Sdz 212-713
- Rivastigmine
Rivastigmine
CAS:123441-03-2
Formula:
C14H22N2O2
Purity:
>98.0%(HPLC)
Color and Shape:
Colorless to Light yellow clear liquid
Molecular weight:
250.34
Ref: 3B-R0250
1g | 212.00 € |
Estimated delivery in United States, on Friday 29 Nov 2024
Rivastigmine
CAS:123441-03-2
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereof
Formula:
C14H22N2O2
Color and Shape:
Yellow Clear Liquid Viscous
Molecular weight:
250.16813
Estimated delivery in United States, on Wednesday 4 Dec 2024
Rivastigmine
CAS:123441-03-2
Rivastigmine (Exelon) is a Cholinesterase Inhibitor, used for therapy of Alzheimer disease.
Formula:
C14H22N2O2
Purity:
99.85%
Color and Shape:
Solid
Molecular weight:
250.34
Ref: TM-T0229
25mg | 51.00 € | ||
50mg | 59.00 € | ||
100mg | 88.00 € | ||
200mg | 105.00 € | ||
500mg | 130.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
CAS:123441-03-2
Formula:
C14H22N2O2
Purity:
98%
Color and Shape:
Liquid
Molecular weight:
250.3367
Ref: IN-DA000KLF
1g | 150.00 € | ||
5g | 489.00 € | ||
25mg | 49.00 € | ||
50mg | 67.00 € | ||
100mg | 64.00 € | ||
250mg | 107.00 € | ||
500mg | 149.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Ref: 7W-GP0564
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Rivastigmine L-Tartrate
Formula:
C14H22N2O2·C4H6O6
Purity:
>98.0%(T)(HPLC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
400.43
Ref: 3B-R0093
1g | 110.00 € | ||
5g | 339.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Rivastigmine
Controlled ProductCAS:123441-03-2
Formula:
C14H22N2O2
Color and Shape:
Neat
Molecular weight:
250.34
Ref: 04-C16815350
50mg | 131.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
(S)-Rivastigmine-d4
Controlled ProductCAS:123441-03-2
Applications Rivastigmine-d4 is an intermediate in the synthesis of Rivastigmine-d4 Tartrate Salt (R541004), the labeled …
Formula:
C14H18D4N2O2
Color and Shape:
Colourless
Molecular weight:
254.36
Ref: TR-R541007
1mg | 314.00 € | ||
10mg | 2,034.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Rivastigmine
CAS:123441-03-2
Purity:
95.0%
Color and Shape:
Liquid, Viscous
Molecular weight:
250.3419952392578
Ref: 10-F462714
1g | 186.00 € | ||
100mg | 77.00 € | ||
250mg | 92.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Rivastigmine
Controlled ProductCAS:123441-03-2
Acetylcholinesterase and butyrylcholinesterase inhibitor
Formula:
C14H22N2O2
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
250.34 g/mol
Ref: 3D-FR15397
1g | 136.00 € | ||
2g | 192.00 € | ||
5g | 346.00 € | ||
10g | 506.00 € | ||
25g | 1,025.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
(S)-Rivastigmine
CAS:123441-03-2
Applications S-Rivastigmine is an isomer of Rivastigmine ( an acetylcholinesterase inhibitor used in the treatment …
Formula:
C14H22N2O2
Color and Shape:
Colourless
Molecular weight:
250.34
Ref: TR-R540995
1g | 340.00 € | ||
500mg | 195.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025